Global Next Generation Cancer Diagnostics Databank Market Report
The Next Generation Cancer Diagnostics market was valued at $8,704.9 Million in 2022, and is projected to reach $18,019.9 Million by 2031 growing at a CAGR of 8.47% from 2023 to 2031. Next-Generation Sequencing segment is expected to be the highest contributor to this market, with $4,346.5 Million in 2022, and is anticipated to reach $9,095.4 Million by 2031, registering a CAGR of 8.60%. DNA Microarrays segment is anticipated to reach $1,017.6 Million by 2031 with the highest CAGR of 13.67%. Next-Generation Sequencing and qPCR & Multiplexing segments collectively expected to account for about 73.4% share of the Next Generation Cancer Diagnostics market in 2022, with the former constituting around 49.9% share. DNA Microarrays and Protein Microarrays segments are expected to witness significant growth rates at a CAGR of 13.67% and 9.96% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 7.6% in the overall Next Generation Cancer Diagnostics market in 2022, and is anticipated to reach 10.1% by 2031.
- 1. Global Next Generation Cancer Diagnostics Market, By Technology
- 1.1. Overview
- 1.2. Next-Generation Sequencing
- 1.2.1 Next-Generation Sequencing Market, By Region
- 1.2.1.1 North America Next-Generation Sequencing Market, By Country
- 1.2.1.2 Europe Next-Generation Sequencing Market, By Country
- 1.2.1.3 Asia-Pacific Next-Generation Sequencing Market, By Country
- 1.2.1.4 Rest of World Next-Generation Sequencing Market, By Country
- 1.3. qPCR & Multiplexing
- 1.3.1 qPCR & Multiplexing Market, By Region
- 1.3.1.1 North America qPCR & Multiplexing Market, By Country
- 1.3.1.2 Europe qPCR & Multiplexing Market, By Country
- 1.3.1.3 Asia-Pacific qPCR & Multiplexing Market, By Country
- 1.3.1.4 Rest of World qPCR & Multiplexing Market, By Country
- 1.4. Lab-on- a- chip
- 1.4.1 Lab-on- a- chip Market, By Region
- 1.4.1.1 North America Lab-on- a- chip Market, By Country
- 1.4.1.2 Europe Lab-on- a- chip Market, By Country
- 1.4.1.3 Asia-Pacific Lab-on- a- chip Market, By Country
- 1.4.1.4 Rest of World Lab-on- a- chip Market, By Country
- 1.5. Protein Microarrays
- 1.5.1 Protein Microarrays Market, By Region
- 1.5.1.1 North America Protein Microarrays Market, By Country
- 1.5.1.2 Europe Protein Microarrays Market, By Country
- 1.5.1.3 Asia-Pacific Protein Microarrays Market, By Country
- 1.5.1.4 Rest of World Protein Microarrays Market, By Country
- 1.6. DNA Microarrays
- 1.6.1 DNA Microarrays Market, By Region
- 1.6.1.1 North America DNA Microarrays Market, By Country
- 1.6.1.2 Europe DNA Microarrays Market, By Country
- 1.6.1.3 Asia-Pacific DNA Microarrays Market, By Country
- 1.6.1.4 Rest of World DNA Microarrays Market, By Country
- 2. Global Next Generation Cancer Diagnostics Market, By Application
- 2.1. Overview
- 2.2. Biomarker Development
- 2.2.1 Biomarker Development Market, By Region
- 2.2.1.1 North America Biomarker Development Market, By Country
- 2.2.1.2 Europe Biomarker Development Market, By Country
- 2.2.1.3 Asia-Pacific Biomarker Development Market, By Country
- 2.2.1.4 Rest of World Biomarker Development Market, By Country
- 2.3. CTC Analysis
- 2.3.1 CTC Analysis Market, By Region
- 2.3.1.1 North America CTC Analysis Market, By Country
- 2.3.1.2 Europe CTC Analysis Market, By Country
- 2.3.1.3 Asia-Pacific CTC Analysis Market, By Country
- 2.3.1.4 Rest of World CTC Analysis Market, By Country
- 2.4. Proteomic Analysis
- 2.4.1 Proteomic Analysis Market, By Region
- 2.4.1.1 North America Proteomic Analysis Market, By Country
- 2.4.1.2 Europe Proteomic Analysis Market, By Country
- 2.4.1.3 Asia-Pacific Proteomic Analysis Market, By Country
- 2.4.1.4 Rest of World Proteomic Analysis Market, By Country
- 2.5. Epigenetic Analysis
- 2.5.1 Epigenetic Analysis Market, By Region
- 2.5.1.1 North America Epigenetic Analysis Market, By Country
- 2.5.1.2 Europe Epigenetic Analysis Market, By Country
- 2.5.1.3 Asia-Pacific Epigenetic Analysis Market, By Country
- 2.5.1.4 Rest of World Epigenetic Analysis Market, By Country
- 2.6. Genetic Analysis
- 2.6.1 Genetic Analysis Market, By Region
- 2.6.1.1 North America Genetic Analysis Market, By Country
- 2.6.1.2 Europe Genetic Analysis Market, By Country
- 2.6.1.3 Asia-Pacific Genetic Analysis Market, By Country
- 2.6.1.4 Rest of World Genetic Analysis Market, By Country
- 3. Global Next Generation Cancer Diagnostics Market, By Cancer Type
- 3.1. Overview
- 3.2. Lung Cancer
- 3.2.1 Lung Cancer Market, By Region
- 3.2.1.1 North America Lung Cancer Market, By Country
- 3.2.1.2 Europe Lung Cancer Market, By Country
- 3.2.1.3 Asia-Pacific Lung Cancer Market, By Country
- 3.2.1.4 Rest of World Lung Cancer Market, By Country
- 3.3. Breast Cancer
- 3.3.1 Breast Cancer Market, By Region
- 3.3.1.1 North America Breast Cancer Market, By Country
- 3.3.1.2 Europe Breast Cancer Market, By Country
- 3.3.1.3 Asia-Pacific Breast Cancer Market, By Country
- 3.3.1.4 Rest of World Breast Cancer Market, By Country
- 3.4. Colorectal Cancer
- 3.4.1 Colorectal Cancer Market, By Region
- 3.4.1.1 North America Colorectal Cancer Market, By Country
- 3.4.1.2 Europe Colorectal Cancer Market, By Country
- 3.4.1.3 Asia-Pacific Colorectal Cancer Market, By Country
- 3.4.1.4 Rest of World Colorectal Cancer Market, By Country
- 3.5. Cervical Cancer
- 3.5.1 Cervical Cancer Market, By Region
- 3.5.1.1 North America Cervical Cancer Market, By Country
- 3.5.1.2 Europe Cervical Cancer Market, By Country
- 3.5.1.3 Asia-Pacific Cervical Cancer Market, By Country
- 3.5.1.4 Rest of World Cervical Cancer Market, By Country
- 3.6. Other Cancer Types
- 3.6.1 Other Cancer Types Market, By Region
- 3.6.1.1 North America Other Cancer Types Market, By Country
- 3.6.1.2 Europe Other Cancer Types Market, By Country
- 3.6.1.3 Asia-Pacific Other Cancer Types Market, By Country
- 3.6.1.4 Rest of World Other Cancer Types Market, By Country
- 4. Global Next Generation Cancer Diagnostics Market, By Function
- 4.1. Overview
- 4.2. Therapeutic Monitoring
- 4.2.1 Therapeutic Monitoring Market, By Region
- 4.2.1.1 North America Therapeutic Monitoring Market, By Country
- 4.2.1.2 Europe Therapeutic Monitoring Market, By Country
- 4.2.1.3 Asia-Pacific Therapeutic Monitoring Market, By Country
- 4.2.1.4 Rest of World Therapeutic Monitoring Market, By Country
- 4.3. Companion Diagnostics
- 4.3.1 Companion Diagnostics Market, By Region
- 4.3.1.1 North America Companion Diagnostics Market, By Country
- 4.3.1.2 Europe Companion Diagnostics Market, By Country
- 4.3.1.3 Asia-Pacific Companion Diagnostics Market, By Country
- 4.3.1.4 Rest of World Companion Diagnostics Market, By Country
- 4.4. Prognostics
- 4.4.1 Prognostics Market, By Region
- 4.4.1.1 North America Prognostics Market, By Country
- 4.4.1.2 Europe Prognostics Market, By Country
- 4.4.1.3 Asia-Pacific Prognostics Market, By Country
- 4.4.1.4 Rest of World Prognostics Market, By Country
- 4.5. Cancer Screening
- 4.5.1 Cancer Screening Market, By Region
- 4.5.1.1 North America Cancer Screening Market, By Country
- 4.5.1.2 Europe Cancer Screening Market, By Country
- 4.5.1.3 Asia-Pacific Cancer Screening Market, By Country
- 4.5.1.4 Rest of World Cancer Screening Market, By Country
- 4.6. Risk Analysis
- 4.6.1 Risk Analysis Market, By Region
- 4.6.1.1 North America Risk Analysis Market, By Country
- 4.6.1.2 Europe Risk Analysis Market, By Country
- 4.6.1.3 Asia-Pacific Risk Analysis Market, By Country
- 4.6.1.4 Rest of World Risk Analysis Market, By Country
- 5. Global Next Generation Cancer Diagnostics Market, By Region
- 5.1. Overview
- 5.2. North America
- 5.2.1 North America Next Generation Cancer Diagnostics Market, By Technology
- 5.2.2 North America Next Generation Cancer Diagnostics Market, By Application
- 5.2.3 North America Next Generation Cancer Diagnostics Market, By Cancer Type
- 5.2.4 North America Next Generation Cancer Diagnostics Market, By Function
- 5.2.5 North America Next Generation Cancer Diagnostics Market, By Country
- 5.2.5.1 U.S.
- 5.2.5.1.1 U.S. Next Generation Cancer Diagnostics Market, By Technology
- 5.2.5.1.2 U.S. Next Generation Cancer Diagnostics Market, By Application
- 5.2.5.1.3 U.S. Next Generation Cancer Diagnostics Market, By Cancer Type
- 5.2.5.1.4 U.S. Next Generation Cancer Diagnostics Market, By Function
- 5.2.5.2 Canada
- 5.2.5.2.1 Canada Next Generation Cancer Diagnostics Market, By Technology
- 5.2.5.2.2 Canada Next Generation Cancer Diagnostics Market, By Application
- 5.2.5.2.3 Canada Next Generation Cancer Diagnostics Market, By Cancer Type
- 5.2.5.2.4 Canada Next Generation Cancer Diagnostics Market, By Function
- 5.3. Europe
- 5.3.1 Europe Next Generation Cancer Diagnostics Market, By Technology
- 5.3.2 Europe Next Generation Cancer Diagnostics Market, By Application
- 5.3.3 Europe Next Generation Cancer Diagnostics Market, By Cancer Type
- 5.3.4 Europe Next Generation Cancer Diagnostics Market, By Function
- 5.3.5 Europe Next Generation Cancer Diagnostics Market, By Country
- 5.3.5.1 Germany
- 5.3.5.1.1 Germany Next Generation Cancer Diagnostics Market, By Technology
- 5.3.5.1.2 Germany Next Generation Cancer Diagnostics Market, By Application
- 5.3.5.1.3 Germany Next Generation Cancer Diagnostics Market, By Cancer Type
- 5.3.5.1.4 Germany Next Generation Cancer Diagnostics Market, By Function
- 5.3.5.2 U.K.
- 5.3.5.2.1 U.K. Next Generation Cancer Diagnostics Market, By Technology
- 5.3.5.2.2 U.K. Next Generation Cancer Diagnostics Market, By Application
- 5.3.5.2.3 U.K. Next Generation Cancer Diagnostics Market, By Cancer Type
- 5.3.5.2.4 U.K. Next Generation Cancer Diagnostics Market, By Function
- 5.3.5.3 France
- 5.3.5.3.1 France Next Generation Cancer Diagnostics Market, By Technology
- 5.3.5.3.2 France Next Generation Cancer Diagnostics Market, By Application
- 5.3.5.3.3 France Next Generation Cancer Diagnostics Market, By Cancer Type
- 5.3.5.3.4 France Next Generation Cancer Diagnostics Market, By Function
- 5.3.5.4 Italy
- 5.3.5.4.1 Italy Next Generation Cancer Diagnostics Market, By Technology
- 5.3.5.4.2 Italy Next Generation Cancer Diagnostics Market, By Application
- 5.3.5.4.3 Italy Next Generation Cancer Diagnostics Market, By Cancer Type
- 5.3.5.4.4 Italy Next Generation Cancer Diagnostics Market, By Function
- 5.3.5.5 Spain
- 5.3.5.5.1 Spain Next Generation Cancer Diagnostics Market, By Technology
- 5.3.5.5.2 Spain Next Generation Cancer Diagnostics Market, By Application
- 5.3.5.5.3 Spain Next Generation Cancer Diagnostics Market, By Cancer Type
- 5.3.5.5.4 Spain Next Generation Cancer Diagnostics Market, By Function
- 5.3.5.6 Rest of Europe
- 5.3.5.6.1 Rest of Europe Next Generation Cancer Diagnostics Market, By Technology
- 5.3.5.6.2 Rest of Europe Next Generation Cancer Diagnostics Market, By Application
- 5.3.5.6.3 Rest of Europe Next Generation Cancer Diagnostics Market, By Cancer Type
- 5.3.5.6.4 Rest of Europe Next Generation Cancer Diagnostics Market, By Function
- 5.4. Asia-Pacific
- 5.4.1 Asia-Pacific Next Generation Cancer Diagnostics Market, By Technology
- 5.4.2 Asia-Pacific Next Generation Cancer Diagnostics Market, By Application
- 5.4.3 Asia-Pacific Next Generation Cancer Diagnostics Market, By Cancer Type
- 5.4.4 Asia-Pacific Next Generation Cancer Diagnostics Market, By Function
- 5.4.5 Asia-Pacific Next Generation Cancer Diagnostics Market, By Country
- 5.4.5.1 China
- 5.4.5.1.1 China Next Generation Cancer Diagnostics Market, By Technology
- 5.4.5.1.2 China Next Generation Cancer Diagnostics Market, By Application
- 5.4.5.1.3 China Next Generation Cancer Diagnostics Market, By Cancer Type
- 5.4.5.1.4 China Next Generation Cancer Diagnostics Market, By Function
- 5.4.5.2 Japan
- 5.4.5.2.1 Japan Next Generation Cancer Diagnostics Market, By Technology
- 5.4.5.2.2 Japan Next Generation Cancer Diagnostics Market, By Application
- 5.4.5.2.3 Japan Next Generation Cancer Diagnostics Market, By Cancer Type
- 5.4.5.2.4 Japan Next Generation Cancer Diagnostics Market, By Function
- 5.4.5.3 South Korea
- 5.4.5.3.1 South Korea Next Generation Cancer Diagnostics Market, By Technology
- 5.4.5.3.2 South Korea Next Generation Cancer Diagnostics Market, By Application
- 5.4.5.3.3 South Korea Next Generation Cancer Diagnostics Market, By Cancer Type
- 5.4.5.3.4 South Korea Next Generation Cancer Diagnostics Market, By Function
- 5.4.5.4 India
- 5.4.5.4.1 India Next Generation Cancer Diagnostics Market, By Technology
- 5.4.5.4.2 India Next Generation Cancer Diagnostics Market, By Application
- 5.4.5.4.3 India Next Generation Cancer Diagnostics Market, By Cancer Type
- 5.4.5.4.4 India Next Generation Cancer Diagnostics Market, By Function
- 5.4.5.5 Indonesia
- 5.4.5.5.1 Indonesia Next Generation Cancer Diagnostics Market, By Technology
- 5.4.5.5.2 Indonesia Next Generation Cancer Diagnostics Market, By Application
- 5.4.5.5.3 Indonesia Next Generation Cancer Diagnostics Market, By Cancer Type
- 5.4.5.5.4 Indonesia Next Generation Cancer Diagnostics Market, By Function
- 5.4.5.6 Rest of Asia
- 5.4.5.6.1 Rest of Asia Next Generation Cancer Diagnostics Market, By Technology
- 5.4.5.6.2 Rest of Asia Next Generation Cancer Diagnostics Market, By Application
- 5.4.5.6.3 Rest of Asia Next Generation Cancer Diagnostics Market, By Cancer Type
- 5.4.5.6.4 Rest of Asia Next Generation Cancer Diagnostics Market, By Function
- 5.5. Rest of World
- 5.5.1 Rest of World Next Generation Cancer Diagnostics Market, By Technology
- 5.5.2 Rest of World Next Generation Cancer Diagnostics Market, By Application
- 5.5.3 Rest of World Next Generation Cancer Diagnostics Market, By Cancer Type
- 5.5.4 Rest of World Next Generation Cancer Diagnostics Market, By Function
- 5.5.5 Rest of World Next Generation Cancer Diagnostics Market, By Country
- 5.5.5.1 Brazil
- 5.5.5.1.1 Brazil Next Generation Cancer Diagnostics Market, By Technology
- 5.5.5.1.2 Brazil Next Generation Cancer Diagnostics Market, By Application
- 5.5.5.1.3 Brazil Next Generation Cancer Diagnostics Market, By Cancer Type
- 5.5.5.1.4 Brazil Next Generation Cancer Diagnostics Market, By Function
- 5.5.5.2 Mexico
- 5.5.5.2.1 Mexico Next Generation Cancer Diagnostics Market, By Technology
- 5.5.5.2.2 Mexico Next Generation Cancer Diagnostics Market, By Application
- 5.5.5.2.3 Mexico Next Generation Cancer Diagnostics Market, By Cancer Type
- 5.5.5.2.4 Mexico Next Generation Cancer Diagnostics Market, By Function
- 5.5.5.3 South Africa
- 5.5.5.3.1 South Africa Next Generation Cancer Diagnostics Market, By Technology
- 5.5.5.3.2 South Africa Next Generation Cancer Diagnostics Market, By Application
- 5.5.5.3.3 South Africa Next Generation Cancer Diagnostics Market, By Cancer Type
- 5.5.5.3.4 South Africa Next Generation Cancer Diagnostics Market, By Function
- 5.5.5.4 Australia
- 5.5.5.4.1 Australia Next Generation Cancer Diagnostics Market, By Technology
- 5.5.5.4.2 Australia Next Generation Cancer Diagnostics Market, By Application
- 5.5.5.4.3 Australia Next Generation Cancer Diagnostics Market, By Cancer Type
- 5.5.5.4.4 Australia Next Generation Cancer Diagnostics Market, By Function
- 5.5.5.5 ROW Countries
- 5.5.5.5.1 ROW Countries Next Generation Cancer Diagnostics Market, By Technology
- 5.5.5.5.2 ROW Countries Next Generation Cancer Diagnostics Market, By Application
- 5.5.5.5.3 ROW Countries Next Generation Cancer Diagnostics Market, By Cancer Type
- 5.5.5.5.4 ROW Countries Next Generation Cancer Diagnostics Market, By Function
- ROW Countries Next Generation Cancer Diagnostics Market Value, By Function, 2022-2031, Million USD LIST OF TABLES
- TABLE 1. Global Next Generation Cancer Diagnostics Market Value, By Technology, 2022-2031, Million USD
- TABLE 2. Next-Generation Sequencing Market Value, By Region, 2022-2031, Million USD
- TABLE 3. North America Next-Generation Sequencing Market Value, By Country, 2022-2031, Million USD
- TABLE 4. Europe Next-Generation Sequencing Market Value, By Country, 2022-2031, Million USD
- TABLE 5. Asia-Pacific Next-Generation Sequencing Market Value, By Country, 2022-2031, Million USD
- TABLE 6. Rest of World Next-Generation Sequencing Market Value, By Country, 2022-2031, Million USD
- TABLE 7. qPCR & Multiplexing Market Value, By Region, 2022-2031, Million USD
- TABLE 8. North America qPCR & Multiplexing Market Value, By Country, 2022-2031, Million USD
- TABLE 9. Europe qPCR & Multiplexing Market Value, By Country, 2022-2031, Million USD
- TABLE 10. Asia-Pacific qPCR & Multiplexing Market Value, By Country, 2022-2031, Million USD
- TABLE 11. Rest of World qPCR & Multiplexing Market Value, By Country, 2022-2031, Million USD
- TABLE 12. Lab-on- a- chip Market Value, By Region, 2022-2031, Million USD
- TABLE 13. North America Lab-on- a- chip Market Value, By Country, 2022-2031, Million USD
- TABLE 14. Europe Lab-on- a- chip Market Value, By Country, 2022-2031, Million USD
- TABLE 15. Asia-Pacific Lab-on- a- chip Market Value, By Country, 2022-2031, Million USD
- TABLE 16. Rest of World Lab-on- a- chip Market Value, By Country, 2022-2031, Million USD
- TABLE 17. Protein Microarrays Market Value, By Region, 2022-2031, Million USD
- TABLE 18. North America Protein Microarrays Market Value, By Country, 2022-2031, Million USD
- TABLE 19. Europe Protein Microarrays Market Value, By Country, 2022-2031, Million USD
- TABLE 20. Asia-Pacific Protein Microarrays Market Value, By Country, 2022-2031, Million USD
- TABLE 21. Rest of World Protein Microarrays Market Value, By Country, 2022-2031, Million USD
- TABLE 22. DNA Microarrays Market Value, By Region, 2022-2031, Million USD
- TABLE 23. North America DNA Microarrays Market Value, By Country, 2022-2031, Million USD
- TABLE 24. Europe DNA Microarrays Market Value, By Country, 2022-2031, Million USD
- TABLE 25. Asia-Pacific DNA Microarrays Market Value, By Country, 2022-2031, Million USD
- TABLE 26. Rest of World DNA Microarrays Market Value, By Country, 2022-2031, Million USD
- TABLE 27. Global Next Generation Cancer Diagnostics Market Value, By Application, 2022-2031, Million USD
- TABLE 28. Biomarker Development Market Value, By Region, 2022-2031, Million USD
- TABLE 29. North America Biomarker Development Market Value, By Country, 2022-2031, Million USD
- TABLE 30. Europe Biomarker Development Market Value, By Country, 2022-2031, Million USD
- TABLE 31. Asia-Pacific Biomarker Development Market Value, By Country, 2022-2031, Million USD
- TABLE 32. Rest of World Biomarker Development Market Value, By Country, 2022-2031, Million USD
- TABLE 33. CTC Analysis Market Value, By Region, 2022-2031, Million USD
- TABLE 34. North America CTC Analysis Market Value, By Country, 2022-2031, Million USD
- TABLE 35. Europe CTC Analysis Market Value, By Country, 2022-2031, Million USD
- TABLE 36. Asia-Pacific CTC Analysis Market Value, By Country, 2022-2031, Million USD
- TABLE 37. Rest of World CTC Analysis Market Value, By Country, 2022-2031, Million USD
- TABLE 38. Proteomic Analysis Market Value, By Region, 2022-2031, Million USD
- TABLE 39. North America Proteomic Analysis Market Value, By Country, 2022-2031, Million USD
- TABLE 40. Europe Proteomic Analysis Market Value, By Country, 2022-2031, Million USD
- TABLE 41. Asia-Pacific Proteomic Analysis Market Value, By Country, 2022-2031, Million USD
- TABLE 42. Rest of World Proteomic Analysis Market Value, By Country, 2022-2031, Million USD
- TABLE 43. Epigenetic Analysis Market Value, By Region, 2022-2031, Million USD
- TABLE 44. North America Epigenetic Analysis Market Value, By Country, 2022-2031, Million USD
- TABLE 45. Europe Epigenetic Analysis Market Value, By Country, 2022-2031, Million USD
- TABLE 46. Asia-Pacific Epigenetic Analysis Market Value, By Country, 2022-2031, Million USD
- TABLE 47. Rest of World Epigenetic Analysis Market Value, By Country, 2022-2031, Million USD
- TABLE 48. Genetic Analysis Market Value, By Region, 2022-2031, Million USD
- TABLE 49. North America Genetic Analysis Market Value, By Country, 2022-2031, Million USD
- TABLE 50. Europe Genetic Analysis Market Value, By Country, 2022-2031, Million USD
- TABLE 51. Asia-Pacific Genetic Analysis Market Value, By Country, 2022-2031, Million USD
- TABLE 52. Rest of World Genetic Analysis Market Value, By Country, 2022-2031, Million USD
- TABLE 53. Global Next Generation Cancer Diagnostics Market Value, By Cancer Type, 2022-2031, Million USD
- TABLE 54. Lung Cancer Market Value, By Region, 2022-2031, Million USD
- TABLE 55. North America Lung Cancer Market Value, By Country, 2022-2031, Million USD
- TABLE 56. Europe Lung Cancer Market Value, By Country, 2022-2031, Million USD
- TABLE 57. Asia-Pacific Lung Cancer Market Value, By Country, 2022-2031, Million USD
- TABLE 58. Rest of World Lung Cancer Market Value, By Country, 2022-2031, Million USD
- TABLE 59. Breast Cancer Market Value, By Region, 2022-2031, Million USD
- TABLE 60. North America Breast Cancer Market Value, By Country, 2022-2031, Million USD
- TABLE 61. Europe Breast Cancer Market Value, By Country, 2022-2031, Million USD
- TABLE 62. Asia-Pacific Breast Cancer Market Value, By Country, 2022-2031, Million USD
- TABLE 63. Rest of World Breast Cancer Market Value, By Country, 2022-2031, Million USD
- TABLE 64. Colorectal Cancer Market Value, By Region, 2022-2031, Million USD
- TABLE 65. North America Colorectal Cancer Market Value, By Country, 2022-2031, Million USD
- TABLE 66. Europe Colorectal Cancer Market Value, By Country, 2022-2031, Million USD
- TABLE 67. Asia-Pacific Colorectal Cancer Market Value, By Country, 2022-2031, Million USD
- TABLE 68. Rest of World Colorectal Cancer Market Value, By Country, 2022-2031, Million USD
- TABLE 69. Cervical Cancer Market Value, By Region, 2022-2031, Million USD
- TABLE 70. North America Cervical Cancer Market Value, By Country, 2022-2031, Million USD
- TABLE 71. Europe Cervical Cancer Market Value, By Country, 2022-2031, Million USD
- TABLE 72. Asia-Pacific Cervical Cancer Market Value, By Country, 2022-2031, Million USD
- TABLE 73. Rest of World Cervical Cancer Market Value, By Country, 2022-2031, Million USD
- TABLE 74. Other Cancer Types Market Value, By Region, 2022-2031, Million USD
- TABLE 75. North America Other Cancer Types Market Value, By Country, 2022-2031, Million USD
- TABLE 76. Europe Other Cancer Types Market Value, By Country, 2022-2031, Million USD
- TABLE 77. Asia-Pacific Other Cancer Types Market Value, By Country, 2022-2031, Million USD
- TABLE 78. Rest of World Other Cancer Types Market Value, By Country, 2022-2031, Million USD
- TABLE 79. Global Next Generation Cancer Diagnostics Market Value, By Function, 2022-2031, Million USD
- TABLE 80. Therapeutic Monitoring Market Value, By Region, 2022-2031, Million USD
- TABLE 81. North America Therapeutic Monitoring Market Value, By Country, 2022-2031, Million USD
- TABLE 82. Europe Therapeutic Monitoring Market Value, By Country, 2022-2031, Million USD
- TABLE 83. Asia-Pacific Therapeutic Monitoring Market Value, By Country, 2022-2031, Million USD
- TABLE 84. Rest of World Therapeutic Monitoring Market Value, By Country, 2022-2031, Million USD
- TABLE 85. Companion Diagnostics Market Value, By Region, 2022-2031, Million USD
- TABLE 86. North America Companion Diagnostics Market Value, By Country, 2022-2031, Million USD
- TABLE 87. Europe Companion Diagnostics Market Value, By Country, 2022-2031, Million USD
- TABLE 88. Asia-Pacific Companion Diagnostics Market Value, By Country, 2022-2031, Million USD
- TABLE 89. Rest of World Companion Diagnostics Market Value, By Country, 2022-2031, Million USD
- TABLE 90. Prognostics Market Value, By Region, 2022-2031, Million USD
- TABLE 91. North America Prognostics Market Value, By Country, 2022-2031, Million USD
- TABLE 92. Europe Prognostics Market Value, By Country, 2022-2031, Million USD
- TABLE 93. Asia-Pacific Prognostics Market Value, By Country, 2022-2031, Million USD
- TABLE 94. Rest of World Prognostics Market Value, By Country, 2022-2031, Million USD
- TABLE 95. Cancer Screening Market Value, By Region, 2022-2031, Million USD
- TABLE 96. North America Cancer Screening Market Value, By Country, 2022-2031, Million USD
- TABLE 97. Europe Cancer Screening Market Value, By Country, 2022-2031, Million USD
- TABLE 98. Asia-Pacific Cancer Screening Market Value, By Country, 2022-2031, Million USD
- TABLE 99. Rest of World Cancer Screening Market Value, By Country, 2022-2031, Million USD
- TABLE 100. Risk Analysis Market Value, By Region, 2022-2031, Million USD
- TABLE 101. North America Risk Analysis Market Value, By Country, 2022-2031, Million USD
- TABLE 102. Europe Risk Analysis Market Value, By Country, 2022-2031, Million USD
- TABLE 103. Asia-Pacific Risk Analysis Market Value, By Country, 2022-2031, Million USD
- TABLE 104. Rest of World Risk Analysis Market Value, By Country, 2022-2031, Million USD
- TABLE 105. Global Next Generation Cancer Diagnostics Market Value, By Region, 2022-2031, Million USD
- TABLE 106. North America Next Generation Cancer Diagnostics Market Value, By Technology, 2022-2031, Million USD
- TABLE 107. North America Next Generation Cancer Diagnostics Market Value, By Application, 2022-2031, Million USD
- TABLE 108. North America Next Generation Cancer Diagnostics Market Value, By Cancer Type, 2022-2031, Million USD
- TABLE 109. North America Next Generation Cancer Diagnostics Market Value, By Function, 2022-2031, Million USD
- TABLE 110. North America Next Generation Cancer Diagnostics Market Value, By Country, 2022-2031, Million USD
- TABLE 111. U.S. Next Generation Cancer Diagnostics Market Value, By Technology, 2022-2031, Million USD
- TABLE 112. U.S. Next Generation Cancer Diagnostics Market Value, By Application, 2022-2031, Million USD
- TABLE 113. U.S. Next Generation Cancer Diagnostics Market Value, By Cancer Type, 2022-2031, Million USD
- TABLE 114. U.S. Next Generation Cancer Diagnostics Market Value, By Function, 2022-2031, Million USD
- TABLE 115. Canada Next Generation Cancer Diagnostics Market Value, By Technology, 2022-2031, Million USD
- TABLE 116. Canada Next Generation Cancer Diagnostics Market Value, By Application, 2022-2031, Million USD
- TABLE 117. Canada Next Generation Cancer Diagnostics Market Value, By Cancer Type, 2022-2031, Million USD
- TABLE 118. Canada Next Generation Cancer Diagnostics Market Value, By Function, 2022-2031, Million USD
- TABLE 119. Europe Next Generation Cancer Diagnostics Market Value, By Technology, 2022-2031, Million USD
- TABLE 120. Europe Next Generation Cancer Diagnostics Market Value, By Application, 2022-2031, Million USD
- TABLE 121. Europe Next Generation Cancer Diagnostics Market Value, By Cancer Type, 2022-2031, Million USD
- TABLE 122. Europe Next Generation Cancer Diagnostics Market Value, By Function, 2022-2031, Million USD
- TABLE 123. Europe Next Generation Cancer Diagnostics Market Value, By Country, 2022-2031, Million USD
- TABLE 124. Germany Next Generation Cancer Diagnostics Market Value, By Technology, 2022-2031, Million USD
- TABLE 125. Germany Next Generation Cancer Diagnostics Market Value, By Application, 2022-2031, Million USD
- TABLE 126. Germany Next Generation Cancer Diagnostics Market Value, By Cancer Type, 2022-2031, Million USD
- TABLE 127. Germany Next Generation Cancer Diagnostics Market Value, By Function, 2022-2031, Million USD
- TABLE 128. U.K. Next Generation Cancer Diagnostics Market Value, By Technology, 2022-2031, Million USD
- TABLE 129. U.K. Next Generation Cancer Diagnostics Market Value, By Application, 2022-2031, Million USD
- TABLE 130. U.K. Next Generation Cancer Diagnostics Market Value, By Cancer Type, 2022-2031, Million USD
- TABLE 131. U.K. Next Generation Cancer Diagnostics Market Value, By Function, 2022-2031, Million USD
- TABLE 132. France Next Generation Cancer Diagnostics Market Value, By Technology, 2022-2031, Million USD
- TABLE 133. France Next Generation Cancer Diagnostics Market Value, By Application, 2022-2031, Million USD
- TABLE 134. France Next Generation Cancer Diagnostics Market Value, By Cancer Type, 2022-2031, Million USD
- TABLE 135. France Next Generation Cancer Diagnostics Market Value, By Function, 2022-2031, Million USD
- TABLE 136. Italy Next Generation Cancer Diagnostics Market Value, By Technology, 2022-2031, Million USD
- TABLE 137. Italy Next Generation Cancer Diagnostics Market Value, By Application, 2022-2031, Million USD
- TABLE 138. Italy Next Generation Cancer Diagnostics Market Value, By Cancer Type, 2022-2031, Million USD
- TABLE 139. Italy Next Generation Cancer Diagnostics Market Value, By Function, 2022-2031, Million USD
- TABLE 140. Spain Next Generation Cancer Diagnostics Market Value, By Technology, 2022-2031, Million USD
- TABLE 141. Spain Next Generation Cancer Diagnostics Market Value, By Application, 2022-2031, Million USD
- TABLE 142. Spain Next Generation Cancer Diagnostics Market Value, By Cancer Type, 2022-2031, Million USD
- TABLE 143. Spain Next Generation Cancer Diagnostics Market Value, By Function, 2022-2031, Million USD
- TABLE 144. Rest of Europe Next Generation Cancer Diagnostics Market Value, By Technology, 2022-2031, Million USD
- TABLE 145. Rest of Europe Next Generation Cancer Diagnostics Market Value, By Application, 2022-2031, Million USD
- TABLE 146. Rest of Europe Next Generation Cancer Diagnostics Market Value, By Cancer Type, 2022-2031, Million USD
- TABLE 147. Rest of Europe Next Generation Cancer Diagnostics Market Value, By Function, 2022-2031, Million USD
- TABLE 148. Asia-Pacific Next Generation Cancer Diagnostics Market Value, By Technology, 2022-2031, Million USD
- TABLE 149. Asia-Pacific Next Generation Cancer Diagnostics Market Value, By Application, 2022-2031, Million USD
- TABLE 150. Asia-Pacific Next Generation Cancer Diagnostics Market Value, By Cancer Type, 2022-2031, Million USD
- TABLE 151. Asia-Pacific Next Generation Cancer Diagnostics Market Value, By Function, 2022-2031, Million USD
- TABLE 152. Asia-Pacific Next Generation Cancer Diagnostics Market Value, By Country, 2022-2031, Million USD
- TABLE 153. China Next Generation Cancer Diagnostics Market Value, By Technology, 2022-2031, Million USD
- TABLE 154. China Next Generation Cancer Diagnostics Market Value, By Application, 2022-2031, Million USD
- TABLE 155. China Next Generation Cancer Diagnostics Market Value, By Cancer Type, 2022-2031, Million USD
- TABLE 156. China Next Generation Cancer Diagnostics Market Value, By Function, 2022-2031, Million USD
- TABLE 157. Japan Next Generation Cancer Diagnostics Market Value, By Technology, 2022-2031, Million USD
- TABLE 158. Japan Next Generation Cancer Diagnostics Market Value, By Application, 2022-2031, Million USD
- TABLE 159. Japan Next Generation Cancer Diagnostics Market Value, By Cancer Type, 2022-2031, Million USD
- TABLE 160. Japan Next Generation Cancer Diagnostics Market Value, By Function, 2022-2031, Million USD
- TABLE 161. South Korea Next Generation Cancer Diagnostics Market Value, By Technology, 2022-2031, Million USD
- TABLE 162. South Korea Next Generation Cancer Diagnostics Market Value, By Application, 2022-2031, Million USD
- TABLE 163. South Korea Next Generation Cancer Diagnostics Market Value, By Cancer Type, 2022-2031, Million USD
- TABLE 164. South Korea Next Generation Cancer Diagnostics Market Value, By Function, 2022-2031, Million USD
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook